Your browser doesn't support javascript.
loading
Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.
Zhou, Pengcheng; Chen, Jiali; He, Jing; Zheng, Ting; Yunis, Joseph; Makota, Victor; Alexandre, Yannick O; Gong, Fang; Zhang, Xia; Xie, Wuxiang; Li, Yuhui; Shao, Miao; Zhu, Yanshan; Sinclair, Jane E; Miao, Miao; Chen, Yaping; Short, Kirsty R; Mueller, Scott N; Sun, Xiaolin; Yu, Di; Li, Zhanguo.
Afiliação
  • Zhou P; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Chen J; The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • He J; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Zheng T; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Yunis J; Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China.
  • Makota V; The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • Alexandre YO; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
  • Gong F; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Zhang X; Department of Laboratory Medicine, Affiliated Hospital of Jiangnan University, Wuxi, China.
  • Xie W; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Li Y; Peking University Clinical Research Institute, Peking University Health Science Center, Beijing, China.
  • Shao M; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Zhu Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Sinclair JE; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.
  • Miao M; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.
  • Chen Y; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Short KR; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Mueller SN; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia.
  • Sun X; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
  • Yu D; Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing Key Laboratory for Rheumatism Mechanism and Immune Diagnosis (BZ0135), Beijing, China.
  • Li Z; Department of Immunology and Infectious Disease, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
PLoS Pathog ; 17(10): e1009858, 2021 10.
Article em En | MEDLINE | ID: mdl-34618873
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Oportunistas / Interleucina-2 / Linfócitos T CD8-Positivos / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Oportunistas / Interleucina-2 / Linfócitos T CD8-Positivos / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article